Menu
Back to Journals » Drug Design, Development and Therapy
Drug Design, Development and Therapy
ISSN: 1177-8881
Editor-in-Chief: Prof. Dr. Frank Boeckler
An international, peer-reviewed, open access journal that spans the spectrum of drug design and development through to clinical applications. The journal is characterized by the rapid reporting of application notes, reviews, original research and clinical studies in all therapeutic areas. Clinical outcomes, patient safety, and programs for the development and effective, safe, and sustained use of medicines will be a feature of the journal.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (4245)
- Volume 18, 2024 (206)
- Volume 17, 2023 (283)
- Volume 16, 2022 (316)
- Volume 15, 2021 (399)
- Volume 14, 2020 (477)
- Volume 13, 2019 (387)
- Volume 12, 2018 (382)
- Volume 11, 2017 (330)
- Volume 10, 2016 (374)
- Volume 9, 2015 (543)
- Volume 8, 2014 (231)
- Volume 7, 2013 (143)
- Volume 6, 2012 (42)
- Volume 5, 2011 (40)
- Volume 4, 2010 (35)
- Volume 3, 2009 (27)
- Volume 2, 2008 (29)
- Volume 1, 2007 (1)
Latest articles:
- 5 records -
The Discovery of GIT1/β-Pix Inhibitors: Virtual Screening and Biological Evaluation of New Small-molecule Compounds with Anti-invasion Effect in Gastrointestinal Neoplasms
Wang C, Gu J, Li H, Zhao B, Yu T, Guo CL, Huang M, Jiang W, Ouyang Q
Drug Design, Development and Therapy 2024, 18:3075-3088
Published Date: 16 July 2024
Therapeutic Potential of Solanum Alkaloids with Special Emphasis on Cancer: A Comprehensive Review
Manoharan R, Nair CS, Eissa N, Cheng H, Ge P, Ren M, Jaleel A
Drug Design, Development and Therapy 2024, 18:3063-3074
Published Date: 16 July 2024
Mapping Theme Trends and Research Frontiers in Dexmedetomidine Over Past Decade: A Bibliometric Analysis
Chen Z, Zuo Z, Song X, Zuo Y, Zhang L, Ye Y, Ma Y, Pan L, Zhao X, Jin Y
Drug Design, Development and Therapy 2024, 18:3043-3061
Published Date: 16 July 2024
Evaluating the Therapeutic Potential of Ublituximab in the Treatment of MS: Design, Development and Place in Therapy
Martin SJ, Guenette M, Oh J
Drug Design, Development and Therapy 2024, 18:3025-3042
Published Date: 16 July 2024
The Application Potential of the Regulation of Tregs Function by Irisin in the Prevention and Treatment of Immune-Related Diseases
Wang Z, Xu J, Mo L, Zhan R, Zhang J, Liu L, Jiang J, Zhang Y, Bai Y
Drug Design, Development and Therapy 2024, 18:3005-3023
Published Date: 16 July 2024